Aqueous Concentrations and PGE2 Inhibition of Ketorolac 0.4% vs. Bromfenac 0.09% in Cataract Patients: Trough Drug Effects

NCT00469690 Phase 4 COMPLETED

The purpose of this study is to compare the ability of two different topical NSAIDs (non-steroidal anti-inflammatory medications used for pain relief) to reach the back of the eye and to stop inflammation. The study will conclude on the day of your cataract surgery.

Details

Lead sponsor	Innovative Medical
Phase	Phase 4
Status	COMPLETED
Enrolment	58
Start date	2007-05
Completion	2008-05

Conditions

• Cataract

Interventions

• Acular, Xibrom

Primary outcomes

• Aqueous concentrations — 8 months

Countries

United States